Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Chicago, Illinois

CNS trials open to children and teens in Chicago, IL

12 CNS studies open to children and teens are recruiting participants at sites in Chicago as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Chicago at a glance

  • 12 studies are recruiting at a site in Chicago.
  • By phase: Phase 1/2 (1), Phase 3 (8), No phase (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (9), university, hospital or other (3).
  • By research area: Depression (4), Migraine (3), Schizophrenia (3), Epilepsy (2).
  • Most recent update to one of these records: November 18, 2026.

Depression studies recruiting in Chicago

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Our Voices Matter: Intervention for Depression in Youth

    • No phase
    • Ages 15 to 20
    • All sexes
    Sponsor
    Seattle Children's Hospital
    Study site
    Ann & Robert H. Lurie Children's Hospital of Chicago
    Registry record
    NCT07216326 · updated
  2. Rise & Thrive: Community-Engagement Intervention for Stress and Depression in Youth.

    • No phase
    • Ages 15 to 20
    • All sexes
    Sponsor
    Seattle Children's Hospital
    Study site
    Ann & Robert H. Lurie Children's Hospital of Chicago
    Registry record
    NCT07554326 · updated
  3. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    Ann & Robert H. Lurie Children's Hospital of Chicago
    Registry record
    NCT06372964 · updated
  4. Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury

    • No phase
    • Ages 14 to 18
    • All sexes
    Sponsor
    Northwestern University
    Study site
    Northwestern University
    Registry record
    NCT07224165 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Chicago, IL on ClinicalTrials.gov.

Epilepsy studies recruiting in Chicago

  1. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Ann & Robert H. Lurie Children's Hospital of Chicago
    Registry record
    NCT05419492 · updated
  2. A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

    • Phase 3
    • From 1 day, up to 18 years
    • All sexes
    Sponsor
    Praxis Precision Medicines
    Study site
    Praxis Research Site
    Registry record
    NCT07019922 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Chicago, IL on ClinicalTrials.gov.

Migraine studies recruiting in Chicago

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Chicago Headache Center & Research Institute
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Chicago Headache Center & Research Institute
    Registry record
    NCT04743141 · updated
  3. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Chicago Headache Center & Research Institute /ID# 248625
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Chicago, IL on ClinicalTrials.gov.

Schizophrenia studies recruiting in Chicago

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    EmVenio Research Center - Prime Healthcare
    Registry record
    NCT07288567 · updated
  2. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    EmVenio Research Center - Prime Healthcare
    Registry record
    NCT07424404 · updated
  3. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigator Site
    Registry record
    NCT05303064 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Chicago, IL on ClinicalTrials.gov.

Ask about studies near Chicago

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call